| Document |
Document Title |
|
WO/1992/000338A1 |
A polyurethane or polyurethane-urea elastomeric composition, characterized in that the composition is a reaction product of: (A) a soft segment macrodiol which is either: (i) a homopolymer represented by formula (I): HO-[(CH¿2?)¿n?O]¿...
|
|
WO/1991/011207A1 |
The invention relates to the use of polymers made from glycolic or lactic acid and polyhydric alcohols as coating materials for surgical suture material which can be resorbed by the human or animal body.
|
|
WO/1991/005036A2 |
An absorbed protein-independent cell-adhesive surface is disclosed. The treated surface comprises a chemically derivatized material to which small peptides, having less than 12 amino acid residues and including YIGSR, RGD or REDV amino a...
|
|
WO/1990/015629A1 |
A medical material based on lactate polymer is heat-treated for at least 10 minutes at a temperature ranging from 100°C to the melting point of the polymer while continuously discharging gases present in the system.
|
|
WO/1990/012104A1 |
The invention relates to a microbiological process for the production of polyesters and utilizes bacteria of the Pseudomonas fluorescens rRNA branch according to the phylogenetic classification of De Vos and De Ley, which bacteria are ca...
|
|
WO/1990/008793A1 |
This invention provides a biocompatible polyester having an improved hydrolyzability and a method for producing the same by introducing sugar molecules into the molecular structure of the polymer having repeating glycolic and/or lactic a...
|
|
WO/1990/007575A1 |
A hydrophilic substitute of a bicontinuous cubic phase in equilibrium is polymerized and unpolymerized components are subsequently removed and replaced with water, creating a hydrogel which is locally highly cross-linked but of high wate...
|
|
WO/1990/007545A2 |
A stabilized, highly regular, biocompatible microporous material having a highly regular pore system, arising from the polymerisation of an equilibrium cubic phase and incorporating a plurality of biologically active agents in the pore s...
|
|
WO/1990/005157A1 |
The invention concerns a continuous process for manufacturing resorbable polyesters.
|
|
WO/1990/003783A1 |
Systems for delivery of biologically active materials employing novel polylactide composition containing segments of poly(R-lactide) interlocked with segments of poly(S-lactide) as the carrier.
|
|
WO/1989/011857A1 |
An improved method and composition for preventing adhesions during surgery. Tissue surfaces and surgical articles involved in the surgery are coated with a solution of a hydrophilic, polymeric material prior to manipulation of the tissue...
|
|
WO/1989/010940A1 |
New polysaccharide esters are disclosed, and more precisely esters of acidic polysaccharides chosen from the group formed by carboxymethylcellulose, carboxymethyl starch and carboxymethylchitin. These new esters and some esters of the ty...
|
|
WO/1989/010941A1 |
Inter and/or intramolecular cross-linked esters of acid polysaccharides are disclosed in which a part or all of the carboxy groups are esterified with hydroxyl groups of the same molecule and/or of different molecules of the acid polysac...
|
|
WO/1989/008672A1 |
A hydrophilic, thermoplastic polyurethane polymer of improved dimensional stability and mechanical strength having an average molecular weight of from about 10,000 to about 200,000 produced by reacting (A) an organic diisocyanate with (B...
|
|
WO/1989/005664A1 |
This invention relates to medical devices formed totally or in part from homopolymers or copolymers comprising recurring carbonate moieties.
|
|
WO/1989/005616A1 |
Biomolecules are attached to supporting surfaces through the utilization of long chain chemical spacers, the spacers separating the surfaces and biomolecule groups by extended spacer lengths of at least 25 Angstroms. The spacers desirabl...
|
|
WO/1989/004674A1 |
The invention relates to structures and/or devices which are in an intimate tissue contact or are installable at least partly to the inside of tissues and/or organs and/or body cavities (ducts), and which have some function (especially c...
|
|
WO/1988/010260A1 |
A meso-lactide having a melting point of 52.8°C, process for manufacturing it, and its use in the manufacture of resorbable polymers and copolymers.
|
|
WO/1988/008127A1 |
The invention relates to a sealing and insulating construction of a sensor for pressurized working conditions. The construction comprises a pressure balancing chamber (1) which is open towards the pressurized space, a sensor (4) which is...
|
|
WO/1988/004181A1 |
A unitary, sterile fluid dispensing assembly and a method of forming the assembly (10) includes forming a fluid-filled container (12) with a vinyl dispensing port (14) and forming a fluid transfer set (17) with a vinyl spike connector (4...
|
|
WO/1988/002623A1 |
The biocompatibility of biomaterials having solid surfaces is improved through coating the same with biocompatible agents. The method for modifying the solid surface to improve biocompatibility employs molecules of a biocompatible agent ...
|
|
WO/1988/000062A1 |
A ligature material comprises a base made of a biodegradable polymer covered by a layer of a copolymer of N-vinyl pyrrolidone with alkyl acrylate and/or alkyl methacrylate, containing an antimicrobial preparation or a preparation mix the...
|
|
WO/1987/002880A1 |
Human implantable collagen based materials having desirable properties with respect to antigenicity and possessing mechanical strength and flexibility are prepared by pretreating a collagen based material so that some of the amino acid s...
|
|
WO/1986/000020A1 |
A composite surgical suture of extraordinary high knot strength and capable of use over a range of United States Pharmacopeia (USP) suture sizes is prepared by coating or covering a core of a fiber-forming synthetic polymer material havi...
|
|
WO/1985/004413A1 |
Processes for preparaing biodegradable collagen-based matrices in sponge or sheet form wherein in one embodiment a collagen-based material including a collagen selected from the group consisting of types I, II and III collagens is freeze...
|
|
WO/1985/001507A1 |
Use of hydrophilic surfaces in order to restrict the adhesion of bacteria on objects coming into contact with bacteria, such as objects within the food stuff industry, and within health care. The hydrophilic surface can be neutral or cha...
|
|
WO/1985/000969A1 |
Novel physiologically acceptable polymeric compositions and methods of using the same. Numerous polymeric compositions have been tried as alloplastic implants in mammals. They are disadvantageous because they require surgical implantatio...
|
|
WO/1984/001508A1 |
Absorbable, substantially amorphous surgical fasteners having good in vivo strength-retaining and absorption characteristics may be made of copolymers of lactide and glycolide made from 70-85%m lactide and 15-30%m glycolide provided the ...
|
|
WO/1984/000303A1 |
A process for the manufacture of filament material by dry- or wet- spinning a spinning mixture comprising a polyester material and an additive, particularly a polyurethane material.
|
|
WO/1984/000302A1 |
Biocompatible, highly antithrombogenic material for reconstructive surgery, which is based on poly(L-lactic acid) and/or poly(dL-lactic acid) and segmented polyester urethanes or polyether urethanes.
|
|
WO/1983/003974A1 |
A process for the preparation of implantable biological tissue, and in particular bioprosthetic heart valves, which are prone to calcification after implantation. The process includes the incorporation of biocompatible polymers into the ...
|
|
WO/1983/003346A1 |
In a method for treating prostheses comprised essentially of a biologically active material (1), selected superficial areas (4; 10, 12; 16) are subjected to a biological inactivation process. Consequently, an additive layer (S(+)) or a s...
|
|
WO/1983/003193A1 |
Implantable porous prostheses for use as bone or hard tissue replacements anywhere in the body. The porous implants comprise loose, individual polymeric particles of a specified size, coated with a hydrophilic material and barium sulfate...
|
|
WO/1983/001736A1 |
A bandage material for forming in place an orthopedic cast comprising a pliant, large mesh fabric carrier formed from a knit of a high-strength, high-modulus yarn with a low moisture pick-up, the fabric carrier having openings of relativ...
|
|
WO/1982/003174A1 |
The corpuscles held together form a main element containing drugs and resisting to pressure and traction. The union of the corpuscles can be obtained by juxtaposing them or by sticking them together. One can obtain, in a simple way, the ...
|
|
WO/1982/001989A1 |
Porous implantable oral prosthesis which can be used to replicate and replace any hard tissue portion of the mouth such as bone and teeth. The prosthesis comprises sintered polymeric particles coated with a hydrophilic material. The poly...
|
|
WO/1981/001368A1 |
Catgut suturing filament protected by a flexible polymer sheath that is slowly hydrolytically degradable and impervious to body fluid degratative enzymes. The sheath is prepared by coating the catgut filament with an isocyanate capped po...
|
|
JP2024515282A |
The present invention provides an elongate flexible suture having a needle, a connecting end attached to the needle, and an opposite free end, and the suture attached to the needle or at the connecting end. and at least one elongate exte...
|
|
JP2024514509A |
A compressible aid is provided for use with a staple cartridge. In one exemplary embodiment, the compressible aid is formed from at least one molten bioabsorbable polymer and is configured to be releasably retained on the cartridge and d...
|
|
JP7455834B2 |
A disposable coating applicator container for applying a coating of a therapeutic agent upon an object to be coated. The disposable coating applicator container includes a sealable container, the sealable container having a container bot...
|
|
JP2024512494A |
The present invention relates to suture materials comprising at least one polymer and at least one eutectic mixture. The polymer can be a biocompatible polymer such as polycaprolactone or PLGA. The eutectic mixture may include maleic aci...
|
|
JP7439235B2 |
The present disclosure relates to radiopaque PVA polymers where the PVA has a first pendant group and a second pendant group, wherein the first pendant group comprises a first phenyl group bearing 1 to 5 iodine atoms, and the second pend...
|
|
JP7437874B2 |
The present invention relates to surgical sutures and threads for introducing skin-augmenting materials into human tissues, such as the skin.
|
|
JP2024507545A |
SUMMARY OF THE INVENTION Surgical staple line reinforcement materials and methods of making and uses thereof are disclosed herein. [Selection diagram] Figure 1
|
|
JP7434283B2 |
A method of reducing surgical site infection (SSI), using a coated medical device having a tissue penetrating surface and an abradable coating on the medical device comprising at least one antimicrobial agent in the coating.
|
|
JP2024020772A |
An object of the present invention is to provide a surgical suture thread and a surgical suture needle that emit light efficiently using ultraviolet rays, can be easily identified with the naked eye, and have little effect on the human b...
|
|
JP7430722B2 |
A novel process is disclosed for extruding an absorbable glycolide/lactide block copolymer into multifilament suture fibers. The block copolymer preferably consists of about 50/50 mole % of Glycolide/Lactide in the center segment and the...
|
|
JP7429645B2 |
A braided structure that includes a core and a sheath is provided. The core includes a yarn formed at least in part from an aromatic polymer (e.g., an aromatic polyester/liquid crystalline polymer or an aramid polymer), and the sheath, w...
|
|
JP7423547B2 |
The present invention concerns fluorescent polymeric coating films visible in near-infrared light for coating a medical device, and a method for preparing said NIR visible polymeric coating films.
|
|
JP7387429B2 |
Disclosed are chelating co-polymer compositions that are soluble in aqueous media and chelate essential metals, methods of preparation and uses thereof. The chelating compositions are comprised of two or more different monomers, at least...
|
